1. Home
  2. CGEM vs TALK Comparison

CGEM vs TALK Comparison

Compare CGEM & TALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEM
  • TALK
  • Stock Information
  • Founded
  • CGEM 2016
  • TALK 2012
  • Country
  • CGEM United States
  • TALK United States
  • Employees
  • CGEM N/A
  • TALK N/A
  • Industry
  • CGEM Biotechnology: Pharmaceutical Preparations
  • TALK Medical/Nursing Services
  • Sector
  • CGEM Health Care
  • TALK Health Care
  • Exchange
  • CGEM Nasdaq
  • TALK Nasdaq
  • Market Cap
  • CGEM 530.0M
  • TALK 443.4M
  • IPO Year
  • CGEM 2021
  • TALK N/A
  • Fundamental
  • Price
  • CGEM $8.18
  • TALK $2.52
  • Analyst Decision
  • CGEM Strong Buy
  • TALK Buy
  • Analyst Count
  • CGEM 6
  • TALK 6
  • Target Price
  • CGEM $28.17
  • TALK $4.50
  • AVG Volume (30 Days)
  • CGEM 331.3K
  • TALK 1.5M
  • Earning Date
  • CGEM 08-07-2025
  • TALK 08-05-2025
  • Dividend Yield
  • CGEM N/A
  • TALK N/A
  • EPS Growth
  • CGEM N/A
  • TALK N/A
  • EPS
  • CGEM N/A
  • TALK 0.02
  • Revenue
  • CGEM N/A
  • TALK $194,359,000.00
  • Revenue This Year
  • CGEM N/A
  • TALK $22.39
  • Revenue Next Year
  • CGEM N/A
  • TALK $20.33
  • P/E Ratio
  • CGEM N/A
  • TALK $144.85
  • Revenue Growth
  • CGEM N/A
  • TALK 19.88
  • 52 Week Low
  • CGEM $6.85
  • TALK $1.60
  • 52 Week High
  • CGEM $20.96
  • TALK $4.36
  • Technical
  • Relative Strength Index (RSI)
  • CGEM 54.88
  • TALK 40.41
  • Support Level
  • CGEM $7.42
  • TALK $2.47
  • Resistance Level
  • CGEM $8.70
  • TALK $2.65
  • Average True Range (ATR)
  • CGEM 0.38
  • TALK 0.11
  • MACD
  • CGEM 0.09
  • TALK 0.00
  • Stochastic Oscillator
  • CGEM 63.12
  • TALK 34.04

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About TALK Talkspace Inc.

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Share on Social Networks: